{
    "clinical_study": {
        "@rank": "127698", 
        "acronym": "SCI", 
        "arm_group": {
            "arm_group_label": "stem cell [ MNCs ]", 
            "arm_group_type": "Other", 
            "description": "transplantation of autologous stem cell  [MNCs ]"
        }, 
        "brief_summary": {
            "textblock": "This Study is a single arm,Phase I/II , single centre trial to check active comparing the\n      safety and efficacy of Bone marrow derived autologous cell(100 million per dose) trial to be\n      conducted for 36 months."
        }, 
        "brief_title": "Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Spinal Cord Injury.", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "A spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma\n      instead of disease.[1] Depending on where the spinal cord and nerve roots are damaged, the\n      symptoms can vary widely, from pain to paralysis to incontinence.[2][3] Spinal cord injuries\n      are described at various levels of \"incomplete\", which can vary from having no effect on the\n      patient to a \"complete\" injury which means a total loss of function.Injuries at any level\n      can cause:Increased muscle tone (spasticity),Loss of normal bowel and bladder control (may\n      include constipation, incontinence, bladder spasms),Numbness,Sensory changes Pain,Weakness,\n      paralysis. This Study is a single arm,Phase I/II , single centre trial to check active\n      comparing the safety and efficacy of Bone marrow derived autologous cell(100 million per\n      dose) trial to be conducted for 36 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient should suffer from Spinal cord injury.\n\n          -  willingness to undergo bone marrow derived autologous cell therapy.\n\n          -  patient those provide fully Informed consent form for the study.\n\n          -  Ability and willingness to regular visit to hospital and follow up during the\n             protocol Procedures.\n\n          -  traumatic Injury of spinal cord  with complete or partial damage by MRI and Spinal\n             cord injury level should be below C4\n\n        Exclusion Criteria:\n\n          -  Patient with pre- existing or current systemic disease such as Lung,\n             liver,(exception:history of uncomplicated hepatitis A)gastrointestinal,cardiac  ,\n             immunodeficiency(HIV)\n\n          -  History of life threatening allergic  or immune - mediated reaction.\n\n          -  haemodynamically unstable patients.\n\n          -  patient suffer from peripheral muscular dystrophy.\n\n          -  lactating and pregnant woman\n\n          -  alcohol drug abuse /dependence\n\n          -  positive test result for hepatitis A and Hepatitis B OR C\n\n          -  Major-traumatic brain injury and patient with  psychiatric illness ."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833975", 
            "org_study_id": "00103"
        }, 
        "intervention": {
            "arm_group_label": "stem cell [ MNCs ]", 
            "description": "Intra thecal transplantation of Autologous stem cell [MNCs],100millions per dose in 3 divided doses at interval of 10 days.", 
            "intervention_name": "Transplantation of Autologous stem cell [MNCs] .", 
            "intervention_type": "Biological", 
            "other_name": "Autologous stem cell[MNCs] ."
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Spinal Cord Injury stem cell", 
        "lastchanged_date": "April 15, 2013", 
        "location": {
            "contact": {
                "email": "sac2751982@gmail.com", 
                "last_name": "Sachin P Jamadar, D ORTHO", 
                "phone": "8888788880"
            }, 
            "contact_backup": {
                "email": "drsmitabhoyar@rediffmail.com", 
                "last_name": "Smita S Bhoyar, BAMS.PGCR", 
                "phone": "9372620569", 
                "phone_ext": "S"
            }, 
            "facility": {
                "address": {
                    "city": "Pune", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "411009"
                }, 
                "name": "Chaitanya Hospital"
            }, 
            "investigator": {
                "last_name": "Anant E Bagul, MS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury .", 
        "overall_contact": {
            "email": "sac2751982@gmail.com", 
            "last_name": "sachin S Jamadar, Dortho", 
            "phone": "+918888788880"
        }, 
        "overall_contact_backup": {
            "email": "drsmitabhoyar@rediff.com", 
            "last_name": "Smita s Bhoyar, B.A.M.S.PGCR", 
            "phone": "9372620569"
        }, 
        "overall_official": {
            "affiliation": "CHAITANYA HOSPITAL", 
            "last_name": "ANANT E BAGUL, M.S", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Improvement in overall sensory for motor control using Frankel score.", 
            "safety_issue": "Yes", 
            "time_frame": "6 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833975"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chaitanya Hospital, Pune", 
            "investigator_full_name": "Dr. Sachin Jamadar", 
            "investigator_title": "C0-  Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement in pain sensation  and   Significant changes in Muscle Tones from base line", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "-Improvement in sensory and motor dysfunction using ASIA( American spinal cord injury association ) Scale", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "Significant changes in Muscle Tones and Improvement in pain sensation from base line", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }
        ], 
        "source": "Chaitanya Hospital, Pune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chaitanya Hospital, Pune", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}